Veradermics, Incorporated (NYSE:MANE) Stock Has Consensus Price Target of $153.00 According to Brokerages
Veradermics, Incorporated (NYSE:MANE – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The average […]
26 Sep 07:14 · The Markets Daily